Vietnam Pharmaceutical Comprehensive Research Report 2015-2025

Vietnam's pharmaceutical industry uses about 60,000 tons of pharmaceutical materials, of which about 80-90% are imported. In 2019, Vietnam imported US $ 389.68 million of pharmaceutical raw materials and components, down 4.3% compared to the same period in 2018. In Q1/2020, Vietnam spent more than US $ 108 million on importing NPL pharmaceuticals. The country has 198 medicine factories meeting GMP standards of the World Health Organization, 11 factories have invested and reached the standards of advanced countries such as the standards of Europe, the US, Japan and PIC/S. Domestic drugs fully meet 27 groups of pharmacological effects according to the World Health Organization classification. 652 domestic drugs have been published proving the goal This year is the rate of using domestically produced drugs accounting for 22% at the central level, 50% at the provincial level and 75% at the district level.

In general, pharmaceutical production in Q1/2020 prospered over the same period last year. In particular, the group with the strongest increase over the same period in 2019 is other unallocated pharmaceutical products reaching 4.7 million kg, up 81.17% over the same period in 2019.